We analyzed whether lactic acid bacteria could control the expression of IL-4 and IL-13 in activated mast cells and whether these bacteria could inhibit the activity of transcription factors such as GATA-1, GATA-2, NF-AT1, NF-AT2, and NF-κB p65. We previously described a technique for identification of lactic acid bacteria with anti-atopy functionality by confirming increased expression of CD4+/CD25+/foxp3+ in T cells. We also confirmed that a double-culture method increased the antibacterial activity of these lactic acid bacteria against
Staphylococcus aureus
(
S. aureus
). In the present study, we characterized the effect of lactic acid bacteria cultured by this double-culture method on inhibition of allergic inflammatory reactions of RBL-2H3 mast cells, a cellular model of atopic dermatitis. The strongest anti-allergic effects of the lactic acid bacteria were seen in the following order:
Lactococcus lactis
broth cultured with medium containing
Lactobacillus plantarum
culture supernatant >
Lc. lactis
>
Lc. lactis
broth cultured with medium containing
Lb. plantarum
culture supernatant >
Lb. plantarum
. Thus,
Lc. lactis
cultured in medium containing
Lb. plantarum
culture supernatant had the strongest inhibitory effect on the differentiation of mast cells during allergic reactions, which may be mediated through the selective regulation of expression of relevant genes.
Introduction
Immunity can be largely categorized as innate immunity and adaptive immunity, and atopic dermatitis is associated with abnormal innate and adaptive immune responses. In chronic lesions of atopic dermatitis, IFN-γ, IL-5, IL-12, and GM-CSF are up-regulated, and Th1 inflammatory cytokines such as IL-12 and IL-18 play an important role in maintaining chronic state. In contrast, Th2 inflammatory cytokines such as IL-4 and IL-13 are critical to acute lesions of atopic dermatitis. In general, atopic dermatitis is caused by an imbalance of Th1/Th2 reactions and is worsened by increase of IgE due to the suppression of Th1 cells by Th2 cytokines
[26
,
27]
. When the activated mast cells are exposed to the allergen again, it contributes to chronic allergic reactions through the increased transcription of cytokine genes such as IL-4 and IL-13
[31]
. Therefore, if the expression of IL-4 and IL-13 could be controlled, it may be possible to alleviate the allergic reaction or suppress the progression of the acute allergic reaction to the chronic state. It is known that the expression of Th2 cytokines is specifically controlled by transcription factors such as NF-AT, NF-κB p65, and GATA which are selectively expressed in mast cells
[16
,
44]
.
The anti-allergic effect of lactic acid bacteria, especially on atopic dermatitis, was demonstrated in animal model and cell culture system
[14]
. Additionally, a previous report showed that babies from mothers who ingested Lactobacillus GG before and after delivery had significantly reduced onset of atopic dermatitis up to 4 years old
[19]
. Although probiotics is used to treat some diseases, poor understanding of the mechanism of action and strain specific functionality limits the general use of them.
The improvement of living environment and medication are applied for alleviating allergic symptoms, however, there is no prominent and qualified treatment without adverse effect and with prolonged efficacy yet. Many clinical studies evaluated the effect of lactic acid bacteria on immunological diseases such as allergy and atopic dermatitis. Some studies reported that intake of fermentation products from
Lactobacillus rhamnosus
,
Bifidobacterium lactis
,
Lb. acidophillus
, and
Lb. casei
had strain-specific therapeutic effects on allergy
[25
,
40]
. Various studies also showed that probiotics, killed lactic acid bacteria, and lactic acid bacteria lysates induced anti-cancer effect
[29]
, improved absorption of lactose and milk proteins
[15]
, lower serum cholesterol levels
[42]
, treatment for rheumatoid arthritis
[5]
, and intestinal regulation
[20]
.
In our previous report
[18]
, we screened functional lactic acid bacteria having immuno-stimulating activity and anti-allergic effect by using FACS analysis and developed media composition for optimal culture condition. We also tested antimicrobial activity of lactic acid bacteria against
Staphylococcus aureus
. Based on the increase of CD4+/CD25+/foxp3+ T cell subpopulation, the immuno-stimulating effect of
Lactobacillus plantarum
ATCC 8014 (
Lb. plantarum
) was higher than that of
Lactococcus lactis
subsp.
lactis
ATCC 11454 (
Lc. lactis
). The antimicrobial activity against
Starphylococcus aureus
was stronger in
Lc. Lactis
compared to
Lb. plantarum
. No increase in antimicrobial activity was observed when
Lb. plantarum
was cultured in medium containing
Lc. lactis
culture supernatant. In contrast, the antimicrobial activity against
S. aureus
was increased when
Lc. lactis
was cultured in medium containing
Lb. plantarum
culture broth. The maximal antimicrobial activity of lactic acid bacteria was shown when
Lc. Lactis
was cultured in a sterilized medium containing 10% of
Lb. plantarum
culture supernatant. The growth of
S. aureus
exposed to these bacteria was suppressed by 1.29-fold compared to
Lc. lactis
cultured in a conventional medium. This supernatant-added culture method was reported for the first time in the previous report
[18]
.
In the present study, we analyzed whether the homogenate of lactic acid bacteria cultured with the culture method in the previous study
[18]
could control the expression of IL-4 and IL-13 in activated mast cells (RBL-2H3 cell) using real-time PCR and ELISA. We also investigated whether the homogenate could inhibit the expression of transcription factors such as NF-AT1, NF-AT2, NF-κB p65, GATA-1, and GATA-2 by western blot analysis. We experimentally proved the signal transduction mechanism of lactic acid bacteria to inhibit the activity of the mast cells by suppressing the expression of IL-4 and IL-13.
Materials and Methods
- Cell culture
RBL-2H3 cells, a rat mast cell line, were obtained from the Korea Cell Line Bank (Seoul, Korea). These cells were grown in minimal essential medium (MEM, Gibco-BRL, NY, USA) supplemented with 10% fetal bovine serum (FBS, Gibco-BRL, NY, USA). The media contained penicillin (100 U/ml, Gibco-BRL, NY, USA) and streptomycin (100
μ
g/ml, Gibco-BRL, NY, USA). Cells were grown at 37℃ in a humidified 5% CO
2
incubator. RBL-2H3 cells were seed in a 100 mm culture dish and then cultured for 24 hr. A nontreated group was used as a normal group, and a group treated with 50 ng/ml of phorbol 12-myristate 13-acetate (PMA) only and 0.5
μ
M of ionomycin was used as a PI-control group. After culturing, the positive control group (PI-cyclosporin A(CsA)) was treated with 10
μ
g/ml CsA, and the experimental group (PI-LAB) was treated with 10
μ
g/ml lactic acid bacteria homogenate. Cyclosporin A is a strong immunosuppressive agent against the T-cell immunity by inhibiting the secretion of IL-1 and IL-2 and by suppressing the proliferation of T helper cell
[11
,
38]
. After 1 hr incubation they were stimulated with 50 ng/ml of PMA and 0.5
μ
M of ionomycin, and washed with cool PBS 6 hr later. The cells were then collected using a scraper and the supernatant was removed by centrifuge.
- The culture method for lactic acid bacteria
MRS broth supplemented with 10% of either culture medium or supernatant of
Lb. plantarum
was autoclaved. The
Lc. lactis
was inoculated at a content of 1% into the pressured-sterilized broths and was standing-cultured at 35℃ in an incubator for 24 hr to obtain
Lb.p
-cult.+
Lc. lactis
and
Lb.p
-sup.+
Lc. lactis
. To prepare the medium containing
Lb. plantarum
supernatants, the
Lb. plantarum
cultured medium was centrifuged at 10,000 rpm for 10 min and then added.
- Preparation of lactic acid bacteria
The lactic acid bacteria cultured in MRS broth for 24 hr was centrifuged at 9,000 rpm for 10 min, and the collected lactic acid bacteria were washed twice not to be influenced by the low pH generated by the lactic acid. The lactic acid bacteria were then completely broken down by sonication five times for 20 min (output control : 2, duty cycle (%) : 30, and 20 kHz) using an ultrasonic processor (Branson Ultrasonics Model 450, Fisher, MA, USA). Insoluble materials were then removed by centrifuging at 9,000 rpm for 10 min. The collected supernatant was filtered with a 0.45-
μ
m syringe filter to obtain a cytoplasmic fraction.
- Western blot
Cells were treated with a hypotonic buffer using a nuclear extract kit (Abcam, Cambridge CB4, UK) on ice for 15 min and then centrifuged to collect the cytoplasmic fraction. The nuclear remaining in the tube were treated with complete lysis buffer on ice for 30 sec and then centrifuged to obtain the nuclear fraction.
The obtained protein was quantified by BCA protein quantitative analysis. Antibodies for Western blot are anti-NF-AT1, anti-NF-AT2, anti-NF-κB p65, anti-GATA-1, anti-GATA-2, and lamin B antibodies (Thermo Fisher Scientific, MA, USA). The band densities were calculated using Image J software and then used to calculate the inhibition of atopic dermatitis.
- Real-time PCR
Total RNA was extracted using Trizol reagent (Invitrogen, CA, USA). The RNA was added to cDNA synthesis cocktails (deoxynucleotide triphosphate (dNTP), TaKaRa, Tokyo, Japan; moloney murine leukemia virus reverse transcriptase Promega, WI, USA; RNase inhibitor, Promega, WI, USA; RNAzolB, Tel-Test, FL, USA=1:1:1). Primers for IL-4, IL-13, and β-actin were diluted to the proper concentration and added. SYBR Green (SYBR master mix, Applied Biosystems, CA, USA) and cDNA were mixed and real-time PCR (Quantitative Real-Time PCR, Applied Biosystems, CA, USA) was performed under cycling conditions of 95℃ for 3 min, followed by 40 cycles of 95℃ for 15 sec, 60℃ for 15 sec, and 72℃ for 20 sec (
Table 1
)
[12]
.
Primer sequences for real-time PCR analysis
Primer sequences for real-time PCR analysis
- ELISA
100 μl of the antibody was added to a microwell for coating and incubated at 4℃ for 16 hr using a rat IL-4 ELISA kit (BD bioscience, CA, USA) and a IL-13 ELISA kit (Biosource, CA, USA) according to the manufacturer’s instructions. Each of wells was washed with a wash buffer, 200 μl of assay diluents was added to allow blocking for 1 hr, and then the assay was incubated at room temperature. A standard and the supernatant were diluted by 20 fold. The microplate was then washed, and then 100 μl of each of the diluted standard and the supernatant was added. After the well was blocked for 2 hr, it was incubated at room temperature. The microplate was washed and 100 μl of a working detector was added to each of wells, and the wells were then blocked for 1 hr at room temperature. The microplate was then washed, 100 μl of substrate solution was added to each of the wells, and the wells were then incubated at room temperature in a dark room for 30 min. 50 μl of a stop solution was added to each of the wells, and the wells were measured at an absorbance of 450 nm using a microplate spectrophotometer (ELISA reader, Molecular Devices, CA, USA)
[20
,
32]
.
- Statistical analysis
The experimental groups were statistically analyzed by unpaired Student's t-test in statistical analysis software. Significance was defined as
p
<0.05.
Results
- Inhibition of NF-AT transcription factors
Expression of IL-4 and IL-13 is controlled by various transcription factors such as NF-AT1, NF-AT2, GATA-1 and GATA-2
[12
,
22]
. The transcription factor NF-AT is present in a non-activated, i.e., phosphorylated, state in the cytoplasm, and its dephosphorylation is caused by activation of calcineurin, which increases the concentration of Ca
2+
in response to stimulation of an antigen receptor. Dephosphorylated NF-AT is transferred into the nucleus and bound to an antigen receptor response element present in the IL-2 promoter in activated T cells to induce the expression of various cytokines (e.g., IL-3, IL-4, IL-5, GM-CSF, TNF-α, and IFN-γ) and cell surface molecules (e.g., CD40L, FasL, and IL-2Ra) which are essential for inducing an immune reaction in im-munocytes
[9
,
45]
. However, excessive activation of NF-AT causes transplantation rejection, autoimmune diseases, and cardiovascular disorders, so it is necessary to suppress the immune reaction to treat such diseases. The effect of lactic acid bacteria on the expression of NF-AT1 and NF-AT2 in mast cells was analysed by western blot. After treatment with homogenate of the lactic acid bacteria, the expression of NF-AT1 protein in the experimental group stimulated with PI showed the greatest inhibition in the
Lc. lactis
group (63.1%) and the inhibition of the expression of NF-AT2 protein was greatest in the
Lb. p
-sup. +
Lc. lactis
group (68.8%). It is likely that the allergic inflammatory reaction was controlled by inhibition of NF-AT1 and NF-AT2 expression (
Fig. 1
).
Effect of Lc. lactis cultured with medium containing Lb. plantarum culutre supernatants on NF-AT signaling in RBL-2H3 cells induced with PI. Abbreviations: Lb. p-cult + Lc. lactis, Lc. lactis culture broth with a medium containing Lb. plantarum culture broth; Lb. p-sup + Lc. lactis, Lc. lactis culture broth with a medium containing Lb. plantarum supernatants. RBL-2H3 cells were pretreated with cyclosporin A or lactic acid bacteria extract for 1 hr, and then stimulated with PMA-ionomycin for 6 hr. After lysis buffer was added, one part of the lysate was subjected to Western blotting with NF-AT protein. Another part of the lysate was directly subjected to SDS-PAGE and immunoblotting with the indicated antibodies. NF-AT proteins were selected as positive controls for anti-NF-AT1 and anti-NF-AT2 respectively.
- Inhibition of NF-κB p65 transcription factor
It is known that a κB binding motif is present in the 5’ of most inflammation-mediating cytokine genes whose expression could be controlled by the NF-κB transcription factor. Thus, the NF-κB pathway is a converging pathway for the expression of inflammation-mediating cytokines
[3
,
42]
. NF-κB is a complex of proteins consisting of p50 and p65 heterodimers and is maintained at a non-activated state by binding with an inhibitor of NF-κB. When this complex is dissociated by external stimulation, NF-κB moves into the nucleus and binds to a κB element (GGGAATTCCC) in a promoter region of specific genes, thereby inducing the transcription of the genes. Representative inflammation-mediating factors whose transcription is activated through this pathway include TNF-α, IL-2, IL-6, IL-8, lymphotoxin, GM-CSF, β-IFN, and adhesion molecules
[2
,
6
,
8
,
10]
. To determine the effect of the homogenate of lactic acid bacteria, the expression of NF-κB p65 proteins was measured by western blot analysis. The result displayed that the expression of NF-κB p65 proteins in the experimental group stimulated with PI after treatment with
Lb. p
-sup. +
Lc. lactis
was largely down-regulated as compared with the control group (30.0%). Thus, lactic acid bacteria suppresses allergic inflammatory reactions by controlling the signal transduction mechanism of NF-κB (
Fig. 2
).
Effect of Lc. lactis cultured with medium containing Lb. plantarum culture supernatants on NF-κB p65 signaling in RBL-2H3 cells induced with PI. Abbreviations were the same as Fig. 1. RBL-2H3 cells were pretreated with cyclosporin A or lactic acid bacteria extract for 1 hr, and then stimulated with PMA-ionomycin for 6 hr. After lysis buffer was added, one part of the lysate was subjected to western blotting with NF-κB p65 protein. Another part of the lysate was directly subjected to SDS-PAGE and immunoblotting with the indicated antibodies. NF-κB p65 proteins were selected as positive controls for anti-NF-κB p65.
- Inhibition of GATA transcription factors
It is important to systematically express genes for correctly mature cells. GATA transcription factor groups are species-specific transcription factors that play such a role in controlling the expression of GATA-1 and GATA-2 genes. GATA transcription factors have DNA-binding regions and well-maintained zinc finger regions, and these factors cause transcriptional activation by binding to a (A/T)·GATA(A/G) sequence. Their expression is limited to specific tissues and cells; for example, GATA-1 is expressed in red blood cells, megakaryocytes, and mast cells
[16
,
32
,
35]
. GATA plays an important role in the expression of IL-13 in T cells as well as the expression of IL-4 and IL-5. In addition, GATA promotes the transcriptional activation of IL-13 gene in combination with the activation of STAT6 and NF-κB
[33
,
37]
. To confirm the effect of lactic acid bacteria on the expression of GATA-1 and GATA-2 in mast cells, GATA-1 and GATA-2 proteins were measured by western blot analysis. The result showed that the expression of GATA-1 proteins was suppressed in the
Lc. lactis
group stimulated with PI after treatment with lactic acid bacteria (89.0%), and that the expression of GATA-2 proteins was largely suppressed in the
Lb. p
-sup. +
Lc. lactis
group (66.5%). Therefore, lactic acid bacteria suppresses allergic inflammatory reactions by inhibiting the expression of the transcription factors GATA-1 and GATA-2, which blocks the signal transduction mechanism of GATA (
Fig. 3
).
Effect of Lc. lactis cultured with medium containing Lb. plantarum culutre supernatants on GATA-1 and GATA-2 signaling in RBL-2H3 cells induced with PI. Abbreviations were the same as Fig. 1. RBL-2H3 cells were pretreated with cyclosporin A or lactic acid bacteria extract for 1 hr, and then stimulated with PMA-ionomycin for 6 hr. After lysis buffer was added, one part of the lysate was subjected to western blotting with GATA protein. Another part of the lysate was directly subjected to SDS-PAGE and immunoblotting with the indicated antibodies. GATA proteins were selected as positive controls for anti-GATA-1 and anti-GATA-2.
- Inhibition of IL-4 cytokine production
Th2 cytokines are over-expressed in the acute skin lesions of atopic dermatitis. Th2 cytokines induce allergic reactions and also suppress innate immune reactions. In addition, IL-4 generated by the Th2 immune response inhibits recovery after the damage of skin wall, the synthesis of ceramides, and the expression of peptide antibiotics. In addition, IL-4 has been reported to inhibit the expression of desmoglein 3, loricrin, and involucrin, thereby directly deteriorating the function of the skin wall
[1
,
13
,
21
,
23]
. Hypersensitive immunity is basically caused by the production of IgE in response to allergens. IL-4 is essential to produce IgE in allergic reaction. Because IL-4 is produced by T helper 2 cells, Th2 immune reactions play an important role in inducing hypersensitive immunity in response to exogenous antigens. IL-4 expression is controlled through NF-κB and NF-AT transcription factors
[46]
. After RBL-2H3 cells were stimulated with PI after treatment with the lactic acid bacteria homogenate and CsA, their expression of IL-4 mRNA was measured by real-time RT-PCR. The expression of IL-4 mRNA was decreased by 86.4% in the
Lc. lactis
10
μ
g/ml group. As measured by ELISA, IL-4 production was significantly reduced by 91.5% in the
Lc. lactis
10
μ
g/ml group compared with the control group. Thus, the
Lc. lactis
may effectively inhibit allergic inflammatory reactions by down-regulating the production of IL-4 in mast cells. Similar results were shown in the
Lc. lactis
culture with medium containing
Lb. plantarum
supernatant (
Fig. 4
and
5
).
Suppressive effects of Lc. lactis cultured with medium containing Lb. plantarum culture supernatants on IL-4 mRNA RQ of PI-CT in RBL-2H3 cell line. Abbreviations were the same as Fig. 1. RBL-2H3 cells were pretreated with 10 μg/ml cyclosporin A or 5 or 10 μg/ml lactic acid bacteria extract for 1 hr, and then stimulated with PMA-ionomycin for 6 hr. IL-4 mRNA expression was evaluated by real-time PCR. The amount of SYBR green was measured at the end of each cycle. The cycle number at which the emission intensity of the sample rises above the baseline is referred as to the RQ (relative quantitative) and is proportional to the target concentration. Values are expressed as the mean±S.E. from two independent experiments (* p<0.05, ** p<0.01, *** p<0.001).
Suppressive effects of Lc. lactis cultured with medium containing Lb. plantarum culture supernatants on IL-4 production level in RBL-2H3 cell. Abbreviations were the same as Fig. 1. RBL-2H3 cells were pretreated with 10 μg/ml cyclosporin A or 5 or 10 μg/ml lactic acid bacteria extract for 1 hr, and then stimulated with PMA-ionomycin for 24 hr. Values are expressed as the mean±S.E. from two independent experiments (*p<0.05, ** p<0.01, *** p<0.001).
- Inhibition of IL-13 cytokine production
IL-13 is correlated with the physiological changes induced by allergic inflammation in many tissues. The mechanism underlying the control of IL-13 expression in mast cells remains unclear, however, IL-13 expression is known to be controlled by many transcription factors including NF-AT and GATA
[30]
. NF-AT2 plays an important role in controlling IL-13 transcription along with GATA. GATA-2 promotes IL-13 production in mast cells
[22
,
28]
. IL-13 mRNA expression in RBL-2H3 cells treated with CsA and the homogenate of lactic acid bacteria after stimulation with PI was analyzed by real-time PCR, which confirmed that IL-13 mRNA expression was significantly decreased by 64.8% in the
Lb. p
-sup. +
Lc. lactis
10
μ
g/ml group. IL-13 protein production was significantly diminished by 94.9% in the
Lb. p
-sup. +
Lc. lactis
10
μ
g/ml group compared to the control group. Therefore, the
Lc. lactis
culture with medium containing
Lb. plantarum
supernatant could effectively suppress allergic inflammatory reactions by significantly inhibiting the production of IL-13 in mast cells. Similar results were shown in the
Lc. Lactis
(
Fig. 6
and
7
).
Suppressive effects of Lc. lactis cultured with medium containing Lb. plantarum culture supernatants on IL-13 mRNA RQ of PI-CT in RBL-2H3 cell line. Abbreviations were the same as Fig. 1. RBL-2H3 cells were pretreated with 10 μg/ml cyclosporin A or 5 or 10 μg/ml lactic acid bacteria extract for 1 hr, and then stimulated with PMA-ionomycin for 6 hr. IL-13 mRNA expression was analyzed by real-time PCR. The amount of SYBR green was measured at the end of each cycle. The cycle number at which the emission intensity of the sample rises above the baseline is referred as to the RQ (relative quantitative) and is proportional to the target concentration. Values are expressed as the mean±S.E. from two independent experiments (*p<0.05, ** p<0.01, *** p<0.001).
Suppressive effects of Lc. lactis cultured with medium containing Lb. plantarum culture supernatants on IL-13 production. Abbreviations were the same as Fig. 1. RBL-2H3 cells were pretreated with 10 μg/ml cyclosporin A or 5 or 10 μg/ml lactic acid bacteria extract for 1 hr, and then stimulated with PMA-ionomycin for 24 hr. Values are expressed as means±S.E. from two independent experiments (* p<0.05, ** p<0.01, *** p<0.001).
Discussion
To alleviate allergy symptoms, the living environment could be improved or drugs may be used, but the effect is temporary or side effects may occur. Thus, there are no truly effective treatment methods yet. Recently, effective treatment methods having few side effects and a high immune effect have been studied. Clinical studies have found that the effectiveness of therapies for immune disease such as atopic dermatitis could be improved through the ingestion of lactic acid bacteria, which protects from the outbreak of allergies
[34
,
39
,
43]
. It has reported that strain-specific allergies can be cured by eating fermentation products of lactic acid bacteria, such as
Lactobacillus rhamnosus
,
Bifidobacterium lactis
,
Lactobacillus acidophillus
, and
Lactobacillus casei
[40]
. In addition, many studies reported that probiotics, and homogenates of lactic acid bacteria are effective for preventing cancer
[29]
, improving absorption of lactose and milk proteins
[15]
, decreasing cholesterol
[42]
, treating rheumatoid arthritis
[5]
, and enhancing intestinal regulation
[20]
.
Thus, in terms of the functionality of lactic acid bacteria, this study confirmed that antimicrobial and anti-allergic activity was increased by culturing the lactic acid bacteria in a medium containing the supernatant of lactic acid bacteria. We concluded that lactic acid bacteria can effectively suppress allergic inflammatory reactions by inhibiting activity and differentiation of mast cells and by selectively controlling their relevant gene expressions. Based on the protein expression of transcription factors such as NF-AT, NF-κB p65, and GATA, and the expression of IL-4 and IL-13, it is suggested that the lactic acid bacteria homogenate inhibits allergic inflammatory reactions in the order of
Lb. p
-sup. +
Lc. lactis
group,
Lc. lactis
,
Lb. p
-cult. +
Lc. lactis
group, and
Lb. plantarum
by inhibiting the productions of IL-4 and IL-13 in activated mast cells. In particular, the expression of IL-4 and IL-13 mRNA is likely reduced through the blockade of GATA and NF-AT signal transduction, which is mediated by the inhibition of GATA-1, GATA-2, NF-AT1, and NF-AT2 NF-κB p65 transcription factors. This effect is similar to that observed in antimicrobial activity (anti-
S. aureus
) in a previous report
[18]
. Accordingly, it can be considered that when
Lc. Lactis
is cultured in a medium containing
Lb. plantarum
supernatant, it could repress the activity and differentiation of mast cells by regulating related gene expression.
Table 2
shows a summary of anti-atopic effects of lactic acid bacteria based on the culture method in this study (lactic acid bacteria sample 10
μ
g/ml). In the future, we are going to evaluate the anti-atopic effect from this experiment in animal models.
Inhibitory effects ofLc. lactiscultured with medium containingLb. plantarumculture supernatants in atopic diseases
Values are expressed as a percentage of the inhibition rate compared with the PI-control. Inhibition(%) = (PI-contorl–sample)/PI-control ×100 Abbreviations: Lb. p-cult + Lc. lactis, Lc. lactis culture broth with a medium containing Lb. plantarum culture broth; Lb. p-sup. + Lc. lactis, Lc. lactis culture broth with a medium containing Lb. plantarum supernatants.
Albanesi C.
,
Fairchild H. R.
,
Madonna S.
,
Scarponi C.
,
De Pitá O.
,
Leung D. Y.
,
Howell M. D.
2007
IL-4 and IL-13 negatively regulate TNF-alpha- and IFN-gamma-induced beta-defensin expression through STAT-6, suppressor of cytokine signaling (SOCS)-1, and SOCS-3
J. Immunol.
179
984 -
992
DOI : 10.4049/jimmunol.179.2.984
Alkalay I.
,
Yaron A.
,
Hatzubai A.
,
Orian A.
,
Ciechanover A.
,
Ben-Neriah Y.
1995
Stimulation-dependent I kappa B alpha phosphorylation marks the NF-κB inhibitor for degradation via the ubiquitin-proteasome pathway
Proc. Natl. Acad. Sci. USA
92
10599 -
10603
DOI : 10.1073/pnas.92.23.10599
Baeuerle P. A.
,
Baltimore D.
1988
IκB: a specific inhibitor of the NF-κB transcription factor
Science
242
540 -
546
DOI : 10.1126/science.3140380
Beaulieu J.
,
Girad D.
,
Dupont C.
,
Lemieux P.
2009
Inhibition of neutrophil infiltration by a malleable protein matrix of lactic acid bacteria-fermented whey proteins in vivo
Inflamm. Res.
58
133 -
138
DOI : 10.1007/s00011-009-7100-y
Brockman J. A.
,
Scherer D. C.
,
McKinsey T. A.
,
Hall S. M.
,
Qi X.
,
Lee W. Y.
,
Ballard D. W.
1995
Coupling of a signal response domain in I kappa B alpha to multiple pathways for NF-kappa B activation
Mol. Cell. Biol.
15
2809 -
2818
Burgos-Ramos E.
,
Canelles S.
,
Perianes C. A.
,
Arilla F. E.
,
Argente J.
,
Barrios V.
2012
Adipose tissue promotes a serum cytokine profile related to lower insulin sensitivity after chronic central leptin infusion
PLoS One
7
e46893 -
DOI : 10.1371/journal.pone.0046893
Chen Z. J.
,
Parent L.
,
Maniatis T.
1996
Site-specific phosphorylation of IκBα by a novel ubiquitination-dependent protein kinase activity
Cell
84
853 -
862
DOI : 10.1016/S0092-8674(00)81064-8
Finco T. S.
,
Baldwin A. S.
1995
Mechanistic aspects of NF-κB regulation: the emerging role of phosphorylation and proteolysis
Immunity
3
263 -
272
DOI : 10.1016/1074-7613(95)90112-4
Granlund H.
,
Erkko P.
,
Sinisalo M.
,
Reitamo S.
1995
Cyclosporin in atopic dermatitis: time to relapse and effect of intermittent therapy
Br. J. Dermatol.
132
106 -
112
DOI : 10.1111/j.1365-2133.1995.tb08633.x
Harigae H.
,
Takahashi S.
,
Suwabe N.
,
Ohtsu H.
,
Gu L.
,
Yang Z.
,
Tsai F. Y.
,
Kitamura Y.
,
Engel J. D.
,
Yamamoto M.
1998
Differential roles of GATA-1 and GATA-2 in growth and differentiation of mast cells
Genes Cells
3
39 -
50
DOI : 10.1046/j.1365-2443.1998.00166.x
Hatano Y.
,
Terashi H.
,
Arakawa S.
,
Katagiri K.
2005
Interleukin-4 suppresses the enhancement of ceramide synthesis and cutaneous permeability barrier functions induced by tumor necrosis factor-alpha and interferon-gamma in human epidermis
J. Invest. Dermatol.
124
786 -
792
DOI : 10.1111/j.0022-202X.2005.23651.x
Hayashi A.
,
Kimura M.
,
Nakamura Y.
,
Yasui H.
2009
Anti-atopic dermatitis effects and the mechanism of lactic acid bacteria isolated from Mongolian fermented milk
J. Dairy Res.
76
158 -
164
DOI : 10.1017/S0022029908003725
Heyman M.
,
Terpend K.
,
Menard S.
2005
Effects of specific lactic acid bacteria on the intestinal permeability to macromolecules and the inflammatory condition
Acta Paediatr. Suppl.
94
34 -
36
DOI : 10.1080/08035320510043853
Hirasawa N.
,
Sato Y.
,
Fujita Y.
,
Ohuchi K.
2000
Involvement of a phosphatidylinositol 3-kinase-p38 mitogen activated protein kinase pathway in antigen-induced IL-4 production in mast cells
Biochem. Biophys. Acta.
1456
45 -
55
Hirasawa R.
,
Shimizu R.
,
Takahashi S.
,
Osawa M.
,
Takayanagi S.
,
Kato Y.
,
Onodera M.
,
Minegishi N.
,
Yamamoto M.
,
Fukao K.
,
Taniguchi H.
,
Nakauchi H.
,
Iwama A.
2002
Essential and instructive roles of GATA factors in eosinophil development
J. Exp. Med.
195
1379 -
1386
DOI : 10.1084/jem.20020170
Jo Y. R.
,
Kang S. M.
2012
Lactococcus lactis culture method for enhanced depression of inducer in atopic diseases
Kor. J. Microbiol. Biotechnol.
40
310 -
318
DOI : 10.4014/kjmb.1205.05025
Kalliomäki M.
,
Salminen S.
,
Arvilommi H.
,
Kero P.
,
Koskinen P.
,
Isolauri E.
2001
Probiotics in primary prevention of atopic disease: a randomised placebo-controlled trial
Lancet
357
1076 -
1079
DOI : 10.1016/S0140-6736(00)04259-8
Khani S.
,
Hosseini H. M.
,
Taheri M.
,
Nourani M. R.
,
Imani Fooladi A. A.
2012
Probiotics as an alternative strategy for prevention and treatment of human diseases: areview
Inflamm. Allergy Drug Targets
11
79 -
89
DOI : 10.2174/187152812800392832
Kim B. E.
,
Leung D. Y.
,
Boguniewicz M.
,
Howell M. D.
2008
Loricrin and involucrin expression is down-regulated by Th2 cytokines through STAT-6
Clin. Immunol.
126
332 -
337
DOI : 10.1016/j.clim.2007.11.006
Klein M.
,
Klein H. S.
,
Palmetshofer A.
,
Serfling E.
,
Tertilt C.
,
Bopp T.
,
Heib V.
,
Becker M.
,
Taube C.
,
Schild H.
,
Schmitt E.
,
Stassen M.
2006
Specific and redundant roles for NFAT transcription factors in the expression of mast cell-derived cytokines
J. Immunol.
177
6667 -
6674
DOI : 10.4049/jimmunol.177.10.6667
Kurahashi R.
,
Hatano Y.
,
Katagiri K.
2008
IL-4 suppresses the recovery of cutaneous permeability barrier functions in vivo
J. Invest. Dermatol.
128
1329 -
1331
DOI : 10.1038/sj.jid.5701138
Lee H. Y.
,
Kim M. K.
,
Park K. S.
,
Shin E. H.
,
Jo S. H.
,
Kim S. D.
,
Jo E. J.
,
Lee Y. N.
,
Lee C.
,
Baek S. H.
,
Bae Y. S.
2006
Serum amyloid A induces contrary immune responses via formyl peptide receptor-like 1 in human monocytes
Mol. Pharmacol.
70
241 -
248
Lee J.
,
Seto D.
,
Bielory L.
2008
Meta-analysis of clinical trials of probiotics for prevention and treatment of pediatric atopic dermatitis
J. Allergy Clin. Immunol.
121
116 -
121
DOI : 10.1016/j.jaci.2007.10.043
Leung D. Y.
,
Soter N. A.
2001
Cellular and immunologic mechanisms in atopic dermatitis
J. Am. Acad. Dermatol.
44
S1 -
S12
DOI : 10.1067/mjd.2001.109815
Lewin I.
,
Nechushtan H.
,
Ke Q.
,
Razin E.
1993
Regulation of AP-1 expression and activity in antigen-stimulated mast cells: the role played by protein kinase C and the possible involvement of Fos interacting protein
Blood
82
3745 -
3751
Liong M. T.
2008
Roles of probiotics and prebiotics in colon cancer prevention: postulated mechanisms and in-vivo evidence
Int. J. Mol. Sci.
9
854 -
863
DOI : 10.3390/ijms9050854
Masuda A.
,
Yoshikai Y.
,
Kume H.
,
Matsuguchi T.
2004
The interaction between GATA proteins and activator protein-1 promotes the transcription of IL-13 in mast cells
J. Immunol.
173
5564 -
5573
DOI : 10.4049/jimmunol.173.9.5564
Matsubara M.
,
Masaki S.
,
Ohmori K.
,
Karasawa A.
,
Hasegawa K.
2004
Differential regulation of IL-4 expression and degranulation by anti-allergic olopatadine in rat basophilic leukemia (RBL_2H3) cells
Biochem. Pharmacol.
67
1315 -
1326
DOI : 10.1016/j.bcp.2003.12.008
McNagny K.
,
Graf T.
2002
Making eosinophils through subtle shifts in transcription factor expression
J. Exp. Med.
195
43 -
47
DOI : 10.1084/jem.20011145
Min Y. D.
,
Choi C. H.
,
Bark H.
,
Son H. Y.
,
Park H. H.
,
Lee S.
,
Park J. W.
,
Park E. K.
,
Shin H. I.
,
Kim S. H.
2007
Quercetin inhibits expression of inflammatory cytokines through attenuation of NF-kappaB and p38 MAPK in HMC-1 human mast cell line
Inflamm. Res.
56
210 -
215
DOI : 10.1007/s00011-007-6172-9
Moroi M.
,
Uchi S.
,
Nakamura K.
,
Sata S.
,
Shimizu N.
,
Fujji M.
,
Kumagai T.
,
Saito M.
,
Uchiyama K.
,
Watanabe T.
,
Yamaguchi H.
,
Yamamoto T.
,
Takeuchi S.
,
Furue M.
2011
Beneficial effect of a diet containing heat-killed Lactobacillus paracasei K71 on adult type atopic dermatitis
J. Dermatol.
38
131 -
139
DOI : 10.1111/j.1346-8138.2010.00939.x
Nerlov C.
,
Graf T.
1998
PU.1 induces myeloid lineage commitment in multipotent hematopoietic progenitors
Genes Dev.
12
2403 -
2412
DOI : 10.1101/gad.12.15.2403
Ooi L. G.
,
Liong M. T.
2010
Cholesterol-lowering effects of probiotics and prebiotkcs: A revkew of in vivo and in vitro findings
Int. J. Mol. Sci.
11
2499 -
2522
DOI : 10.3390/ijms11062499
Reber L.
,
Vermeulen L.
,
Haegeman G.
,
Frossard N.
2009
Ser276 Phosphorylation of NF-kB p65 by MSK1 Controls SCF Expression in Inflammation
PLoS ONE
4
e4393 -
DOI : 10.1371/journal.pone.0004393
Salek M. S.
,
Finlay A. Y.
,
Luscombe D. K.
,
Allen B. R.
,
Berth-Jones J.
,
Camp R. D.
,
Graham-Brown R. A.
,
Khan G. K.
,
Marks R.
,
Motley R. J.
1993
Cyclosporin greatly improves the quality of life of adults with severe atopic dermatitis. A randomized, double-blind, placebo-controlled trial
Br. J. Dermatol.
129
422 -
430
DOI : 10.1111/j.1365-2133.1993.tb03170.x
Shah M. M.
,
Miyamoto Y.
,
Yamada Y.
,
Yamashita H.
,
Tanaka H.
,
Ezaki T.
,
Nagai H.
,
Inagaki N.
2010
Orally supplemented lactobacillus acidophilus strain L-92 inhibits passive and active cutaneous anaphylaxis as well as 2,4-dinitroflurobenzene and mite fecal antigen induced atopic dermatitis-like skin lesions in mice
Microbiol. Immunol.
54
523 -
533
DOI : 10.1111/j.1348-0421.2010.00251.x
Sistek D.
,
Kelly R.
,
Wickens K.
,
Stanley T.
,
Fitzharris P.
,
Crane J.
2006
Is the effect of probiotics on atopic dermatitis confined to food sensitized children?
Clin. Exp. Allergy
36
629 -
633
DOI : 10.1111/j.1365-2222.2006.02485.x
Sohn E. H.
,
Jang S. A.
,
Joo H.
,
Park S.
,
Kang S. C.
,
Lee C. H.
,
Kim S. Y.
2011
Anti-allergic and anti-inflammatory effects of butanol extract from Arctium Lappa L
Clin. Mol. Allergy
9
4 -
DOI : 10.1186/1476-7961-9-4
Watanabe T.
,
Hamada K.
,
Tategaki A.
,
Kishida H.
,
Kitano M.
,
Miyamoto T.
2009
Oral administration of lactic acid bacteria isolated from traditional south Asian fermented milk ‘dahi’ inhibits the development of atopic dermatitis in NC/Nga mice
J. Nutr. Sci. Vitaminol. (Tokyo)
55
271 -
278
DOI : 10.3177/jnsv.55.271
Weiss D. L.
,
Hural J.
,
Tara D.
,
Timmerman L. A.
,
Henkel G.
,
Brown M. A.
1996
Nuclear factor of activated T cells is associated with a mast cell interleukin 4 transcription complex
Mol. Cell Biol.
16
228 -
235
Wu Z.
,
Turner D. R.
,
Oliveira D. B.
2001
IL-4 gene expression up-regulated by mercury in rat mast cells: a role of oxidant stress in IL-4 transcription
Int. Immunol.
13
297 -
304
DOI : 10.1093/intimm/13.3.297